The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"Cystine-knot cytokines
".
FunFam 7: Luteinizing hormone beta subunit
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 16 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Follicle-stimulating hormone activity GO:0016913
The action characteristic of follicle-stimulating hormone (FSH), a gonadotrophic glycoprotein hormone secreted, in mammals, by the anterior pituitary gland. Upon receptor binding, FSH stimulates growth of Graafian follicles in the ovaries in females, and stimulates the epithelium of the seminiferous tubules to increase spermatogenesis.
|
48 |
A1BN60 (/ISS)
A1BN61 (/ISS)
A1BN61 (/ISS)
O46430 (/ISS)
P01226 (/ISS)
P01226 (/ISS)
P01227 (/ISS)
P01228 (/ISS)
P04837 (/ISS)
P04837 (/ISS)
(38 more) |
Follicle-stimulating hormone receptor binding GO:0031762
Interacting selectively and non-covalently with a follicle-stimulating hormone receptor.
|
15 |
A0A068JIR5 (/ISS)
P01235 (/ISS)
P30984 (/ISS)
P53543 (/ISS)
Q14DX3 (/ISS)
Q14DX4 (/ISS)
Q306L6 (/ISS)
Q49L22 (/ISS)
Q8AXM4 (/ISS)
Q9W6Q7 (/ISS)
(5 more) |
Follicle-stimulating hormone activity GO:0016913
The action characteristic of follicle-stimulating hormone (FSH), a gonadotrophic glycoprotein hormone secreted, in mammals, by the anterior pituitary gland. Upon receptor binding, FSH stimulates growth of Graafian follicles in the ovaries in females, and stimulates the epithelium of the seminiferous tubules to increase spermatogenesis.
|
12 |
P01225 (/IDA)
P01225 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
(2 more) |
Lutropin-choriogonadotropic hormone receptor binding GO:0031775
Interacting selectively and non-covalently with a lutropin-choriogonadotropic hormone receptor.
|
11 |
A0A068JIR5 (/ISS)
P01235 (/ISS)
P30984 (/ISS)
P53543 (/ISS)
Q14DX4 (/ISS)
Q306L6 (/ISS)
Q49L22 (/ISS)
Q9W6Q7 (/ISS)
T1PYH1 (/ISS)
V5QSM4 (/ISS)
(1 more) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
11 |
A0A068JIR5 (/ISS)
P01235 (/ISS)
P30984 (/ISS)
P53543 (/ISS)
Q14DX4 (/ISS)
Q306L6 (/ISS)
Q49L22 (/ISS)
Q9W6Q7 (/ISS)
T1PYH1 (/ISS)
V5QSM4 (/ISS)
(1 more) |
Hormone activity GO:0005179
The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process.
|
7 | A6NKQ9 (/IMP) P01223 (/IMP) P01223 (/IMP) P07732 (/IMP) Q6NT52 (/IMP) Q800P3 (/IMP) Q9DG92 (/IMP) |
Hormone activity GO:0005179
The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process.
|
7 | P01222 (/TAS) P04652 (/TAS) P04652 (/TAS) P0DN86 (/TAS) P0DN86 (/TAS) P0DN87 (/TAS) P0DN87 (/TAS) |
Hormone activity GO:0005179
The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process.
|
6 | H2A0A0 (/IDA) Q5UK78 (/IDA) Q6QMF9 (/IDA) Q6TCF5 (/IDA) Q6TCF6 (/IDA) Q6TCF7 (/IDA) |
Follicle-stimulating hormone activity GO:0016913
The action characteristic of follicle-stimulating hormone (FSH), a gonadotrophic glycoprotein hormone secreted, in mammals, by the anterior pituitary gland. Upon receptor binding, FSH stimulates growth of Graafian follicles in the ovaries in females, and stimulates the epithelium of the seminiferous tubules to increase spermatogenesis.
|
5 | P01225 (/IMP) P01225 (/IMP) Q5QHN8 (/IMP) Q800P4 (/IMP) Q9DG93 (/IMP) |
Follicle-stimulating hormone receptor binding GO:0031762
Interacting selectively and non-covalently with a follicle-stimulating hormone receptor.
|
3 | Q9DG80 (/IDA) Q9DG81 (/IDA) W5UK74 (/IDA) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
2 | P01229 (/TAS) P01229 (/TAS) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
2 | P01225 (/IPI) P01225 (/IPI) |
Follicle-stimulating hormone activity GO:0016913
The action characteristic of follicle-stimulating hormone (FSH), a gonadotrophic glycoprotein hormone secreted, in mammals, by the anterior pituitary gland. Upon receptor binding, FSH stimulates growth of Graafian follicles in the ovaries in females, and stimulates the epithelium of the seminiferous tubules to increase spermatogenesis.
|
2 | Q60687 (/ISO) Q60687 (/ISO) |
Follicle-stimulating hormone activity GO:0016913
The action characteristic of follicle-stimulating hormone (FSH), a gonadotrophic glycoprotein hormone secreted, in mammals, by the anterior pituitary gland. Upon receptor binding, FSH stimulates growth of Graafian follicles in the ovaries in females, and stimulates the epithelium of the seminiferous tubules to increase spermatogenesis.
|
2 | P18427 (/TAS) P18427 (/TAS) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
2 | Q9DG80 (/IPI) W5UK74 (/IPI) |
Lutropin-choriogonadotropic hormone receptor binding GO:0031775
Interacting selectively and non-covalently with a lutropin-choriogonadotropic hormone receptor.
|
1 | Q9DG80 (/IDA) |
There are 60 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
G protein-coupled receptor signaling pathway GO:0007186
A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).
|
44 |
A1BN60 (/ISS)
A1BN61 (/ISS)
A1BN61 (/ISS)
O46430 (/ISS)
P01226 (/ISS)
P01226 (/ISS)
P01227 (/ISS)
P01228 (/ISS)
P04837 (/ISS)
P04837 (/ISS)
(34 more) |
Regulation of signaling receptor activity GO:0010469
Any process that modulates the frequency, rate or extent of a signaling receptor activity. Receptor activity is when a molecule combines with an extracellular or intracellular messenger to initiate a change in cell activity.
|
44 |
A1BN60 (/ISS)
A1BN61 (/ISS)
A1BN61 (/ISS)
O46430 (/ISS)
P01226 (/ISS)
P01226 (/ISS)
P01227 (/ISS)
P01228 (/ISS)
P04837 (/ISS)
P04837 (/ISS)
(34 more) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
15 |
A0A068JIR5 (/ISS)
P01235 (/ISS)
P30984 (/ISS)
P53543 (/ISS)
Q14DX3 (/ISS)
Q14DX4 (/ISS)
Q306L6 (/ISS)
Q49L22 (/ISS)
Q8AXM4 (/ISS)
Q9W6Q7 (/ISS)
(5 more) |
Positive regulation of androgen secretion GO:2000836
Any process that activates or increases the frequency, rate or extent of androgen secretion.
|
15 |
A0A068JIR5 (/ISS)
P01235 (/ISS)
P30984 (/ISS)
P53543 (/ISS)
Q14DX3 (/ISS)
Q14DX4 (/ISS)
Q306L6 (/ISS)
Q49L22 (/ISS)
Q8AXM4 (/ISS)
Q9W6Q7 (/ISS)
(5 more) |
Positive regulation of estradiol secretion GO:2000866
Any process that activates or increases the frequency, rate or extent of estradiol secretion.
|
15 |
A0A068JIR5 (/ISS)
P01235 (/ISS)
P30984 (/ISS)
P53543 (/ISS)
Q14DX3 (/ISS)
Q14DX4 (/ISS)
Q306L6 (/ISS)
Q49L22 (/ISS)
Q8AXM4 (/ISS)
Q9W6Q7 (/ISS)
(5 more) |
G protein-coupled receptor signaling pathway GO:0007186
A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).
|
11 |
P01225 (/IDA)
P01225 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
(1 more) |
Regulation of signaling receptor activity GO:0010469
Any process that modulates the frequency, rate or extent of a signaling receptor activity. Receptor activity is when a molecule combines with an extracellular or intracellular messenger to initiate a change in cell activity.
|
11 |
P01225 (/IDA)
P01225 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
(1 more) |
Estradiol secretion GO:0035938
The regulated release of estradiol into the circulatory system.
|
10 | A5JSW4 (/IMP) G1MS74 (/IMP) P01227 (/IMP) P01231 (/IMP) P45646 (/IMP) P80663 (/IMP) P80664 (/IMP) Q7LZD1 (/IMP) Q8QGF8 (/IMP) Q9PS36 (/IMP) |
Follicle-stimulating hormone signaling pathway GO:0042699
The series of molecular signals mediated by follicle-stimulating hormone.
|
9 | Q6EV79 (/IDA) Q6EV79 (/IDA) Q6EV79 (/IDA) Q6EV79 (/IDA) Q6EV79 (/IDA) Q6EV79 (/IDA) Q6EV79 (/IDA) Q6EV79 (/IDA) Q6EV79 (/IDA) |
Cell-cell signaling GO:0007267
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
|
7 | P01222 (/TAS) P01229 (/TAS) P01229 (/TAS) P0DN86 (/TAS) P0DN86 (/TAS) P0DN87 (/TAS) P0DN87 (/TAS) |
Peptide hormone processing GO:0016486
The generation of a mature peptide hormone by posttranslational processing of a prohormone.
|
7 | P01222 (/TAS) P01225 (/TAS) P01225 (/TAS) P01229 (/TAS) P01229 (/TAS) P0DN86 (/TAS) P0DN86 (/TAS) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
6 | P01229 (/TAS) P01229 (/TAS) P0DN86 (/TAS) P0DN86 (/TAS) P0DN87 (/TAS) P0DN87 (/TAS) |
Spermatogenesis GO:0007283
The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
|
6 | H2A0A0 (/IGI) Q5UK78 (/IGI) Q6QMF9 (/IGI) Q6TCF5 (/IGI) Q6TCF6 (/IGI) Q6TCF7 (/IGI) |
Female gamete generation GO:0007292
Generation of the female gamete; specialised haploid cells produced by meiosis and along with a male gamete takes part in sexual reproduction.
|
6 | P01225 (/TAS) P01225 (/TAS) P0DN86 (/TAS) P0DN86 (/TAS) P0DN87 (/TAS) P0DN87 (/TAS) |
Sex determination GO:0007530
Any process that establishes and transmits the specification of sexual status of an individual organism.
|
6 | H2A0A0 (/IGI) Q5UK78 (/IGI) Q6QMF9 (/IGI) Q6TCF5 (/IGI) Q6TCF6 (/IGI) Q6TCF7 (/IGI) |
Female gonad development GO:0008585
The process whose specific outcome is the progression of the female gonad over time, from its formation to the mature structure.
|
6 | H2A0A0 (/IGI) Q5UK78 (/IGI) Q6QMF9 (/IGI) Q6TCF5 (/IGI) Q6TCF6 (/IGI) Q6TCF7 (/IGI) |
Oocyte maturation GO:0001556
A developmental process, independent of morphogenetic (shape) change, that is required for an oocyte to attain its fully functional state. Oocyte maturation commences after reinitiation of meiosis commonly starting with germinal vesicle breakdown, and continues up to the second meiotic arrest prior to fertilization.
|
5 | H2A0A0 (/IMP) Q5UK78 (/IMP) Q6QMF9 (/IMP) Q6TCF5 (/IMP) Q6TCF6 (/IMP) |
G protein-coupled receptor signaling pathway GO:0007186
A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).
|
5 | P01222 (/TAS) P01225 (/TAS) P01225 (/TAS) P01229 (/TAS) P01229 (/TAS) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
5 | Q60687 (/IDA) Q60687 (/IDA) Q9DG80 (/IDA) Q9DG81 (/IDA) W5UK74 (/IDA) |
Ovulation GO:0030728
The release of a mature ovum/oocyte from an ovary.
|
5 | H2A0A0 (/IMP) Q5UK78 (/IMP) Q6QMF9 (/IMP) Q6TCF5 (/IMP) Q6TCF6 (/IMP) |
Response to testosterone GO:0033574
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a testosterone stimulus.
|
5 | C0HA57 (/IDA) Q9DG92 (/IDA) Q9DG93 (/IDA) Q9W6Q7 (/IDA) Q9W6Q8 (/IDA) |
Progesterone biosynthetic process GO:0006701
The chemical reactions and pathways resulting in the formation of progesterone, a steroid hormone produced in the ovary which prepares and maintains the uterus for pregnancy. Also found in plants.
|
4 | P01225 (/TAS) P01225 (/TAS) P01229 (/TAS) P01229 (/TAS) |
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
|
4 | P0DN86 (/TAS) P0DN86 (/TAS) P0DN87 (/TAS) P0DN87 (/TAS) |
Ovarian follicle development GO:0001541
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
|
3 | Q60687 (/IMP) Q60687 (/IMP) Q6TCF7 (/IMP) |
Response to steroid hormone GO:0048545
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a steroid hormone stimulus.
|
3 | C0HA57 (/IDA) Q9W6Q7 (/IDA) Q9W6Q8 (/IDA) |
Positive regulation of androgen secretion GO:2000836
Any process that activates or increases the frequency, rate or extent of androgen secretion.
|
3 | Q9DG80 (/IMP) Q9DG81 (/IMP) W5UK74 (/IMP) |
Positive regulation of estradiol secretion GO:2000866
Any process that activates or increases the frequency, rate or extent of estradiol secretion.
|
3 | Q9DG80 (/IDA) Q9DG81 (/IDA) W5UK74 (/IDA) |
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
2 | P0DN86 (/TAS) P0DN86 (/TAS) |
Androgen biosynthetic process GO:0006702
The chemical reactions and pathways resulting in the formation of androgens, C19 steroid hormones that can stimulate the development of male sexual characteristics.
|
2 | Q9DG92 (/IDA) Q9DG93 (/IDA) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | P01225 (/IEP) P01225 (/IEP) |
G protein-coupled receptor signaling pathway GO:0007186
A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).
|
2 | Q60687 (/ISO) Q60687 (/ISO) |
Female pregnancy GO:0007565
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
|
2 | P01225 (/TAS) P01225 (/TAS) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
2 | P01225 (/NAS) P01225 (/NAS) |
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
|
2 | P01229 (/TAS) P01229 (/TAS) |
Gene expression GO:0010467
The process in which a gene's sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | Q9DG92 (/IDA) Q9DG93 (/IDA) |
Regulation of signaling receptor activity GO:0010469
Any process that modulates the frequency, rate or extent of a signaling receptor activity. Receptor activity is when a molecule combines with an extracellular or intracellular messenger to initiate a change in cell activity.
|
2 | Q60687 (/ISO) Q60687 (/ISO) |
Positive regulation of steroid biosynthetic process GO:0010893
Any process that increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus.
|
2 | P01225 (/IDA) P01225 (/IDA) |
Positive regulation of steroid biosynthetic process GO:0010893
Any process that increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus.
|
2 | Q60687 (/ISO) Q60687 (/ISO) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
2 | P01225 (/NAS) P01225 (/NAS) |
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
2 | Q9DG92 (/IDA) Q9DG93 (/IDA) |
Response to vitamin A GO:0033189
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin A stimulus.
|
2 | P04652 (/IEP) P04652 (/IEP) |
Response to testosterone GO:0033574
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a testosterone stimulus.
|
2 | P45657 (/TAS) Q7LZD1 (/TAS) |
Follicle-stimulating hormone signaling pathway GO:0042699
The series of molecular signals mediated by follicle-stimulating hormone.
|
2 | Q60687 (/IMP) Q60687 (/IMP) |
Follicle-stimulating hormone signaling pathway GO:0042699
The series of molecular signals mediated by follicle-stimulating hormone.
|
2 | P18427 (/TAS) P18427 (/TAS) |
Response to estrogen GO:0043627
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
|
2 | P04652 (/IEP) P04652 (/IEP) |
Regulation of osteoclast differentiation GO:0045670
Any process that modulates the frequency, rate or extent of osteoclast differentiation.
|
2 | Q60687 (/IMP) Q60687 (/IMP) |
Positive regulation of bone resorption GO:0045780
Any process that activates or increases the frequency, rate or extent of bone resorption.
|
2 | Q60687 (/IMP) Q60687 (/IMP) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
2 | P01225 (/NAS) P01225 (/NAS) |
Response to calcium ion GO:0051592
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.
|
2 | P04652 (/IEP) P04652 (/IEP) |
Sertoli cell proliferation GO:0060011
The multiplication or reproduction of Sertoli cells, resulting in the expansion of the Sertoli cell population. A Sertoli cell is a supporting cell projecting inward from the basement membrane of seminiferous tubules.
|
2 | Q60687 (/IMP) Q60687 (/IMP) |
Response to aromatase inhibitor GO:0061477
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an aromatase inhibitor stimulus.
|
2 | Q9W6Q7 (/IDA) Q9W6Q8 (/IDA) |
Sex determination GO:0007530
Any process that establishes and transmits the specification of sexual status of an individual organism.
|
1 | Q6TCF7 (/IMP) |
Female gonad development GO:0008585
The process whose specific outcome is the progression of the female gonad over time, from its formation to the mature structure.
|
1 | Q6TCF7 (/IMP) |
Response to light stimulus GO:0009416
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a light stimulus, electromagnetic radiation of wavelengths classified as infrared, visible or ultraviolet light.
|
1 | P45646 (/TAS) |
Anatomical structure morphogenesis GO:0009653
The process in which anatomical structures are generated and organized. Morphogenesis pertains to the creation of form.
|
1 | P01222 (/TAS) |
Luteinizing hormone signaling pathway involved in ovarian follicle development GO:0035471
The series of molecular signals initiated by luteinizing hormone binding to a receptor, where the activated receptor signals via downstream effectors that contribute to progression of the ovarian follicle over time, from its formation to the mature structure.
|
1 | O09108 (/IDA) |
Testosterone secretion GO:0035936
The regulated release of testosterone into the circulatory system. Testosterone is an androgen having 17beta-hydroxy and 3-oxo groups, together with unsaturation at C-4-C-5.
|
1 | P07732 (/IMP) |
Androstenedione secretion GO:0035941
The regulated release of androstenedione (androst-4-ene-3,17-dione) into the circulatory system.
|
1 | P07732 (/IMP) |
Progesterone secretion GO:0042701
The regulated release of progesterone, a steroid hormone, by the corpus luteum of the ovary and by the placenta.
|
1 | P07732 (/IMP) |
Testosterone biosynthetic process GO:0061370
The chemical reactions and pathways resulting in the formation of testosterone, an androgen having 17beta-hydroxy and 3-oxo groups, together with unsaturation at C-4 C-5.
|
1 | P07732 (/IMP) |
There are 14 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Follicle-stimulating hormone complex GO:0016914
A gonadotrophic glycoprotein hormone secreted, in mammals, by the anterior pituitary gland; consists of alpha and beta subunits, the latter of which confers hormonal specificity.
|
44 |
A1BN60 (/ISS)
A1BN61 (/ISS)
A1BN61 (/ISS)
O46430 (/ISS)
P01226 (/ISS)
P01226 (/ISS)
P01227 (/ISS)
P01228 (/ISS)
P04837 (/ISS)
P04837 (/ISS)
(34 more) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
35 |
A1BN60 (/ISS)
A1BN61 (/ISS)
A1BN61 (/ISS)
O46430 (/ISS)
P01226 (/ISS)
P01226 (/ISS)
P01227 (/ISS)
P01228 (/ISS)
P04837 (/ISS)
P04837 (/ISS)
(25 more) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
18 |
P01225 (/IDA)
P01225 (/IDA)
P04651 (/IDA)
P04651 (/IDA)
P45646 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
(8 more) |
Follicle-stimulating hormone complex GO:0016914
A gonadotrophic glycoprotein hormone secreted, in mammals, by the anterior pituitary gland; consists of alpha and beta subunits, the latter of which confers hormonal specificity.
|
11 |
P01225 (/IDA)
P01225 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
Q6EV79 (/IDA)
(1 more) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
7 | P01222 (/TAS) P01225 (/TAS) P01225 (/TAS) P01229 (/TAS) P01229 (/TAS) P0DN86 (/TAS) P0DN86 (/TAS) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
7 | O09108 (/IDA) P01225 (/IDA) P01225 (/IDA) P12656 (/IDA) P12656 (/IDA) Q60687 (/IDA) Q60687 (/IDA) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
2 | P01225 (/NAS) P01225 (/NAS) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
2 | P07732 (/IMP) Q7LZD1 (/IMP) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
2 | Q60687 (/ISO) Q60687 (/ISO) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
2 | Q9DG92 (/TAS) Q9DG93 (/TAS) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
2 | Q60687 (/ISO) Q60687 (/ISO) |
Golgi lumen GO:0005796
The volume enclosed by the membranes of any cisterna or subcompartment of the Golgi apparatus, including the cis- and trans-Golgi networks.
|
2 | P01229 (/TAS) P01229 (/TAS) |
Follicle-stimulating hormone complex GO:0016914
A gonadotrophic glycoprotein hormone secreted, in mammals, by the anterior pituitary gland; consists of alpha and beta subunits, the latter of which confers hormonal specificity.
|
2 | Q60687 (/ISO) Q60687 (/ISO) |
Follicle-stimulating hormone complex GO:0016914
A gonadotrophic glycoprotein hormone secreted, in mammals, by the anterior pituitary gland; consists of alpha and beta subunits, the latter of which confers hormonal specificity.
|
2 | P18427 (/TAS) P18427 (/TAS) |